Cargando…

De Novo ESR1 Hotspot Mutation in a Patient With Endometrial Cancer Treated With an Aromatase Inhibitor

Detalles Bibliográficos
Autores principales: Morel, Adeline, Masliah-Planchon, Julien, Bataillon, Guillaume, Becette, Véronique, Morel, Claire, Antonio, Samantha, Girard, Elodie, Bièche, Ivan, Le Tourneau, Christophe, Kamal, Maud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446375/
https://www.ncbi.nlm.nih.gov/pubmed/32914015
http://dx.doi.org/10.1200/PO.18.00398
_version_ 1783574143361351680
author Morel, Adeline
Masliah-Planchon, Julien
Bataillon, Guillaume
Becette, Véronique
Morel, Claire
Antonio, Samantha
Girard, Elodie
Bièche, Ivan
Le Tourneau, Christophe
Kamal, Maud
author_facet Morel, Adeline
Masliah-Planchon, Julien
Bataillon, Guillaume
Becette, Véronique
Morel, Claire
Antonio, Samantha
Girard, Elodie
Bièche, Ivan
Le Tourneau, Christophe
Kamal, Maud
author_sort Morel, Adeline
collection PubMed
description
format Online
Article
Text
id pubmed-7446375
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher American Society of Clinical Oncology
record_format MEDLINE/PubMed
spelling pubmed-74463752020-09-09 De Novo ESR1 Hotspot Mutation in a Patient With Endometrial Cancer Treated With an Aromatase Inhibitor Morel, Adeline Masliah-Planchon, Julien Bataillon, Guillaume Becette, Véronique Morel, Claire Antonio, Samantha Girard, Elodie Bièche, Ivan Le Tourneau, Christophe Kamal, Maud JCO Precis Oncol Case Report American Society of Clinical Oncology 2019-05-21 /pmc/articles/PMC7446375/ /pubmed/32914015 http://dx.doi.org/10.1200/PO.18.00398 Text en © 2019 by American Society of Clinical Oncology https://creativecommons.org/licenses/by/4.0/ Licensed under the Creative Commons Attribution 4.0 License
spellingShingle Case Report
Morel, Adeline
Masliah-Planchon, Julien
Bataillon, Guillaume
Becette, Véronique
Morel, Claire
Antonio, Samantha
Girard, Elodie
Bièche, Ivan
Le Tourneau, Christophe
Kamal, Maud
De Novo ESR1 Hotspot Mutation in a Patient With Endometrial Cancer Treated With an Aromatase Inhibitor
title De Novo ESR1 Hotspot Mutation in a Patient With Endometrial Cancer Treated With an Aromatase Inhibitor
title_full De Novo ESR1 Hotspot Mutation in a Patient With Endometrial Cancer Treated With an Aromatase Inhibitor
title_fullStr De Novo ESR1 Hotspot Mutation in a Patient With Endometrial Cancer Treated With an Aromatase Inhibitor
title_full_unstemmed De Novo ESR1 Hotspot Mutation in a Patient With Endometrial Cancer Treated With an Aromatase Inhibitor
title_short De Novo ESR1 Hotspot Mutation in a Patient With Endometrial Cancer Treated With an Aromatase Inhibitor
title_sort de novo esr1 hotspot mutation in a patient with endometrial cancer treated with an aromatase inhibitor
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446375/
https://www.ncbi.nlm.nih.gov/pubmed/32914015
http://dx.doi.org/10.1200/PO.18.00398
work_keys_str_mv AT moreladeline denovoesr1hotspotmutationinapatientwithendometrialcancertreatedwithanaromataseinhibitor
AT masliahplanchonjulien denovoesr1hotspotmutationinapatientwithendometrialcancertreatedwithanaromataseinhibitor
AT bataillonguillaume denovoesr1hotspotmutationinapatientwithendometrialcancertreatedwithanaromataseinhibitor
AT becetteveronique denovoesr1hotspotmutationinapatientwithendometrialcancertreatedwithanaromataseinhibitor
AT morelclaire denovoesr1hotspotmutationinapatientwithendometrialcancertreatedwithanaromataseinhibitor
AT antoniosamantha denovoesr1hotspotmutationinapatientwithendometrialcancertreatedwithanaromataseinhibitor
AT girardelodie denovoesr1hotspotmutationinapatientwithendometrialcancertreatedwithanaromataseinhibitor
AT biecheivan denovoesr1hotspotmutationinapatientwithendometrialcancertreatedwithanaromataseinhibitor
AT letourneauchristophe denovoesr1hotspotmutationinapatientwithendometrialcancertreatedwithanaromataseinhibitor
AT kamalmaud denovoesr1hotspotmutationinapatientwithendometrialcancertreatedwithanaromataseinhibitor